Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance

Lung cancer coverage, supported by data from the landmark TRACERx collaboration, follows recent approval in breast cancer, providing access to Medicare patients. FREMONT, Calif. --(BUSINESS WIRE)--Feb. 10, 2026-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology,